Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism.
Narita
I
I
Goto
S
S
Saito
N
N
Song
J
J
Omori
K
K
Kondo
D
D
Sakatsume
M
M
Gejyo
F
F
D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D005922:Glomerulonephritis, IGA / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D007674:Kidney Diseases / Q000517:prevention & control; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D012084:Renin-Angiotensin System / Q000187:drug effects; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D007703:Peptidyl-Dipeptidase A